Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Amazon’s healthcare move takes aim at US costs

Founder Jeff Bezos says it enters the realm ‘open-eyed’ about its difficulty

- PMLiVE

Chiesi’s ultra-rare genetic disorder therapy wins European backing

Lamzede is set to become the first approved therapy for Alpha-Mannosidosis

- PMLiVE

EC grants MSD’s Prevymis orphan product designation

The product will gain some market exclusivity benefits in CMV infection

Robert Freisen joins Ablynx

He will take the role of chief scientific officer, effective March 1

- PMLiVE

Akari Therapeutics strengthens board

Hires Michael Grissinger and Dr Peter Feldschreiber

Microsoft brings machine learning to genetics collaboration

Will work with Adaptive Biotechnologies on the human immune system

The ‘Million Hour Challenge’

AstraZeneca employees save two million hours through simplification

dengue fever mosquito

Takeda gets FDA fast-track status for Zika vaccine

The phase I candidate also has the backing of US federal funding body BARDA

Roche Basel Switzerland

Roche wins CHMP backing for Hemlibra

Haemophilia A treatment on course for European approval

- PMLiVE

EMA’s Amsterdam home will not be ready in time

Staff will initially move to a temporary building in the city after Brexit

- PMLiVE

Sobi names Holly May VP of sales and marketing, US

She will work with the biopharma’s commercial and patient access teams

Professor Carole Longson moves from NICE to the ABPI

She joins the UK pharma body as its chief scientific officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links